| Hope Tyler Adair, OTR/L | |
|
1300 Riverside Ave Ste 100, Fort Collins, CO 80524-4351 | |
| (970) 663-6142 | |
| (970) 692-5310 |
| Full Name | Hope Tyler Adair |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1300 Riverside Ave Ste 100, Fort Collins, Colorado |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801671896 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OT.0008118 (Colorado) | Primary |
| Provider Name | Rebound Sports & Physical Therapy P.c |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780680926 PECOS PAC ID: 0042106098 Enrollment ID: O20040225001165 |
News Archive
A web-based system that allows preschools and child care centers to report illnesses to local public health departments could improve the detection of disease outbreaks and allow resources to be mobilized more quickly, according to University of Michigan research to be presented Saturday, Oct. 11 at the American Academy of Pediatrics (AAP) National Conference & Exhibition in San Diego.
Sixty percent of children with ADHD in a recent study demonstrated persistence of symptoms into their mid-20's, and 41 percent had both symptoms and impairment as young adults.
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
Fossil remains of the human pelvis are rare because the pelvic bones do not preserve very well. Therefore, it has remained unclear when human sex differences in the pelvis evolved: jointly with upright walking, or later, together with the large human brains.
Cell Therapeutics, Inc. today announced that the U.S. Food and Drug Administration's Division of Oncology Products 1 has notified CTI that CTI's October 2011 resubmitted New Drug Application is considered a complete, Class 2 response to the FDA's April 2010 complete response letter.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hope Tyler Adair, OTR/L 107 W 29th St Ste 100, Loveland, CO 80538-2200 Ph: (970) 663-6142 | Hope Tyler Adair, OTR/L 1300 Riverside Ave Ste 100, Fort Collins, CO 80524-4351 Ph: (970) 663-6142 |
News Archive
A web-based system that allows preschools and child care centers to report illnesses to local public health departments could improve the detection of disease outbreaks and allow resources to be mobilized more quickly, according to University of Michigan research to be presented Saturday, Oct. 11 at the American Academy of Pediatrics (AAP) National Conference & Exhibition in San Diego.
Sixty percent of children with ADHD in a recent study demonstrated persistence of symptoms into their mid-20's, and 41 percent had both symptoms and impairment as young adults.
Trius Therapeutics, Inc. announced that the first patient has been dosed in its Phase 3 clinical study of the oral dosage form of torezolid phosphate for the treatment of acute bacterial skin and skin structure infections (ABSSSI). The double-blind, active control, pivotal study is designed to compare the efficacy and safety of once-daily oral administration of 200 milligrams of torezolid phosphate for six days of treatment with the efficacy and safety of twice-daily oral administration of 600 milligrams of linezolid (Zyvox®) for 10 days of treatment.
Fossil remains of the human pelvis are rare because the pelvic bones do not preserve very well. Therefore, it has remained unclear when human sex differences in the pelvis evolved: jointly with upright walking, or later, together with the large human brains.
Cell Therapeutics, Inc. today announced that the U.S. Food and Drug Administration's Division of Oncology Products 1 has notified CTI that CTI's October 2011 resubmitted New Drug Application is considered a complete, Class 2 response to the FDA's April 2010 complete response letter.
› Verified 4 days ago
Wendy Sultzman, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1815 Rosemary Ct, Fort Collins, CO 80528 Phone: 970-219-2439 | |
Mrs. Denise Moharsky, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2955 W Stuart St Apt 5, Fort Collins, CO 80526 Phone: 714-274-4643 | |
Peak & Bounds Incorporated Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 638 Endicott St, Fort Collins, CO 80524 Phone: 757-897-2839 | |
Amanda Jensen, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3307 S College Ave, Ste. 108, Fort Collins, CO 80525 Phone: 970-407-9999 | |
Ms. Patricia Ann Atherly, M.S., OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4101 Seneca St, Fort Collins, CO 80526 Phone: 970-490-3066 | |
Kristen Nicole Jensen, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 5055 S Lemay Ave, Fort Collins, CO 80525 Phone: 970-223-0880 | |
Mrs. Nichole Marie Kain, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2350 Limon Dr, Covell Care, Fort Collins, CO 80525 Phone: 720-295-1607 |